Lysosomal and Rare Disorders Research and Treatment Center — Fairfax, Virginia

Lysosomal and Rare Disorders Research and Treatment Center is a clinical research site located in Fairfax, Virginia, United States 22030.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Lysosomal and Rare Disorders Research and Treatment Center has participated in 22 clinical trials with 12 currently active.

Therapeutic areas: Pompe Disease, Fabry Disease, Gaucher Disease.

Sponsors: Shionogi, Idorsia Pharmaceuticals Ltd., Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfax

Browse all research sites in Virginia · View every site in Fairfax

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lysosomal and Rare Disorders Research and Treatment Center?

Lysosomal and Rare Disorders Research and Treatment Center has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lysosomal and Rare Disorders Research and Treatment Center conducted?

Lysosomal and Rare Disorders Research and Treatment Center has 22 clinical trials on record, with 12 currently active. Their work covers Pompe Disease, Fabry Disease, Gaucher Disease.

Is Lysosomal and Rare Disorders Research and Treatment Center accredited by Crixeo Clinical Trials?

Lysosomal and Rare Disorders Research and Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lysosomal and Rare Disorders Research and Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.